As CAR-T therapies continue to evolve, improved care coordination, earlier patient referrals and enhanced support systems can ...

The Decipher genomic test could help doctors decide which high-risk prostate cancer patients need abiraterone hormone therapy ...

Novocure (Nasdaq: NVCR) announced today that it has entered into a clinical trial collaboration and supply agreement with Verastem Oncology to evaluate the use of Novocure’s Tumor Treating Fields ...

(n=6) remain disease-free more than two years after treatment 80% of patients treated with SYNC-T Therapy SV-102 (n=15) alive ...

By Dennis Thompson HealthDay ReporterMONDAY, Oct. 26, 2026 (HealthDay News) — Starting survivorship care for patients with ...

For many people with breast cancer, the journey from their diagnosis to treatment is just the beginning of the road to ...

Lung cancer is still a leading cause of cancer death, but that rate is half what it was in the 1990s, partly because newly developed treatments are working.

The country star announced in September that he’d been diagnosed with multiple myeloma ...

Prostate cancer surgery removes the prostate, but for men with high-risk disease, it doesn't always end the story. Cancer can return, spread, or require additional treatment. Researchers are looking ...

In patients with extensive-stage small cell lung cancer (ES-SCLC), tarlatamab, a bispecific T-cell engager, plus durvalumab ...

An experimental drug that uses messenger RNA to deliver a vaccine customized to a patient’s tumors effectively prevented skin cancer recurrence in a large-scale clinical trial, according to new ...

A retrospective cohort of 269 breast cancer patients found that GLP-1 receptor agonists produced significant but markedly ...